Search
Lisata Therapeutics Inc
LSTAAdd to Watchlist
0.990USD
-0.040-3.87%
Close 07-31 16:00（ET）Quotes delayed by 15 min
8.75MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Lisata Therapeutics Inc is 7.33, ranking 296 out of 385 in the Biotechnology & Medical Research industry. The average price target is 15.00, with a high of 15.00 and a low of 9.00.
Analyst Rating
Based on
3
analysts
Hold
Current Rating
15.000
Target Price
+1276.15%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Lisata Therapeutics Inc
LSTA
3
Beigene Ltd
ONC
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
Ionis Pharmaceuticals Inc
IONS
25
Insmed Inc
INSM
23
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Lisata Therapeutics Inc's price target?
Analysts forecast that Lisata Therapeutics Inc's price target is USD 15.00, with the highest forecast at USD 15.00 and the lowest forecast at USD 9.00.
What is the analyst rating for Lisata Therapeutics Inc?
Based on the ratings of Lisata Therapeutics Inc's stock from 3 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.